Abstract:OBJECTIVE:To explore clinical and muscular pathological features of statin-induced myopathy.METHODS:Nine patients were enrolled in this study, who were diagnosed as statin-induced myopathy by muscle biopsy in Peking University First Hospital from April, 2012 to October, 2014. The clinical data and pathological findings were analyzed.RESULTS:The exposure time to statins varied from 4 days to 4 years in the total of 9 patients, 6 males and 3 females, with the average age of 63 ± 6 (55 to 74) years old. Three patients suffered from myalgia and 6 patients complained of weakness mainly at the proximal limbs, while no symptoms occured in 3 patients. Serum creatine kinase (CK) increased in all patients with the maximum value varied from 468 to 8 000 U/L. Serum myositis antibodies were tested in 7 patients and all were negative. Electromyogram was performed in six patients with myogenic damage found in 2 patients. MRI of bilateral thigh muscle was carried out in six patients with muscle edema and mild fatty infiltration found in 2 patients. All patients underwent skeletal muscle biopsy with histochemical and immunohistochemical staining. The main muscular pathological features were muscle fiber atrophy, necrosis, regeneration and increased lipid droplets. Ragged blue fiber, cytochrome C oxidase-negative muscle fibers and decreased NADH activity were observed in some patients. MHC-I expressed in the sarcolemma of muscle fibers at various levels. Mild C5b-9 staining was found in the endomysium, capillary and cytoplasm. Symptoms and the level of CK were improved in 7 patients after discontinuing statins or changing to another statin, while the immunosuppressive therapy were used in 2 patients and shown to be effective.CONCLUSIONS:Statin induced myopathy is self-limiting in most patients, with improvement after discontinuation of statins. Few patients with autoimmune necrotic myopathy need immunosuppressive therapy.

Color-dependent motion illusions in stationary images and their phenomenal dimorphism.

Statin-Induced Autoimmune Myopathy: A Diagnostic Challenge in Muscle Weakness

[On the diagnosis of renovascular hypertonia].

[Jaw orthodontic treatment from view point of the patient and parents].

[The Clinical and Muscular Pathological Features of Statin-Induced Myopathy].

Immune-Mediated Necrotizing Myopathy Manifesting after Five Years of Statin Therapy

Anti-HMGCR myopathy mimicking facioscapulohumeral muscular dystrophy

Statin-induced immune-mediated necrotizing myopathy with concomitant increase of anti-HMGCR and anti-ACHR antibodies

[Etiology and pathogenesis of primary hydrocele in children].

Comparison of three histochemical methods for assaying lactate dehydrogenase in liver.

Narrative Review: Statin-Related Myopathy

Statin-associated myasthenic weakness

The Role of Mitochondria in Statin-Induced Myopathy

Strategic Behaviour in Multi-Agent Systems Able to Perform Temporal Reasoning

An atorvastatin‐induced positive anti‐HMGCR immune‐mediated necrotizing myopathy case

Seizures in relation to head injury.

Simultaneous measurement of multiple active kinase states using polychromatic flow cytometry

Statin-Associated Muscle Symptoms: Identification and Recommendations for Management

[Statin-associated muscle symptoms : performance and quality of life]

Incidence of statin-associated muscle symptoms in patients taking statins with RYR1 or CACNA1S variants

[Neuropeptide Y (NPY)].